Health Catalyst, Inc.
corporate_fare Company Profile
Health Catalyst, Inc. (NASDAQ:HCAT) is a publicly traded company in the Technology sector. Wiseek has independently scored 28 items for HCAT at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-05, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 12 rated 8 or above. Recent SEC coverage for HCAT spans 10-Q, SCHEDULE 13D/A, 8-K, SCHEDULE 13D.
Recent high-impact activity:
- Health Catalyst 10-Q: $40.5M Q3 Profit on Vitalware Gain, $122.5M Impairment, Debt Wiped Out
- Health Catalyst Posts $40.5M Q3 Net Income
- Activist Palogic Raises Stake to 7.1% and Demands Business Plan, R&D Cost Split
- Health Catalyst Appoints Simeon Kohl as CEO; Ben Albert Moves to Chief Business Officer
- Health Catalyst Finalizes Vitalware Sale, Pays Off Debt, and Posts Q2 Upside
Financial Snapshot
Short Interest & Short Volume
7.18 days to coverFINRA reported short interest of 1,952,692 shares in HCAT as of the October 30, 2026 settlement, a 5.6% decrease from the prior period — about 7.2 days to cover at its recent average daily volume. On November 20, 2026, 25.7% of HCAT volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.